643 research outputs found
The Influence of Manganese Content and Temperature on the Relative FCC/HCP Phase Stability and Strain-Hardening Behavior of High-Manganese TRIP/TWIP Steels
Early and Late Reoperation Rates With Various MIS Techniques for Adult Spinal Deformity Correction.
Study designA multicenter retrospective review of an adult spinal deformity database.ObjectiveWe aimed to characterize reoperation rates and etiologies of adult spinal deformity surgery with circumferential minimally invasive surgery (cMIS) and hybrid (HYB) techniques.MethodsInclusion criteria were age ≥18 years, and one of the following: coronal Cobb >20°, sagittal vertical axis >5 cm, pelvic tilt >20°, and pelvic incidence-lumbar lordosis >10°. Patients with either cMIS or HYB surgery, ≥3 spinal levels treated with 2-year minimum follow-up were included.ResultsA total of 133 patients met inclusion for this study (65 HYB and 68 cMIS). Junctional failure (13.8%) was the most common reason for reoperation in the HYB group, while fixation failure was the most common reason in the cMIS group (14.7%). There was a higher incidence of proximal junctional failure (PJF) than distal junctional failure (DJF) within HYB (12.3% vs 3.1%), but no significant differences in PJF or DJF rates when compared to cMIS. Early (<30 days) reoperations were less common (cMIS = 1.5%; HYB = 6.1%) than late (>30 days) reoperations (cMIS = 26.5%; HYB = 27.7%), but early reoperations were more common in the HYB group after propensity matching, largely due to infection rates (10.8% vs 0%, P = .04).ConclusionsAdult spinal deformity correction with cMIS and HYB techniques result in overall reoperation rates of 27.9% and 33.8%, respectively, at minimum 2-year follow-up. Junctional failures are more common after HYB approaches, while pseudarthrosis/fixation failures happen more often with cMIS techniques. Early reoperations were less common than later returns to the operating room in both groups, but cMIS demonstrated less risk of infection and early reoperation when compared with the HYB group
Treatment of the Fractional Curve of Adult Scoliosis With Circumferential Minimally Invasive Surgery Versus Traditional, Open Surgery: An Analysis of Surgical Outcomes.
Study Design:Retrospective, multicenter review of adult scoliosis patients with minimum 2-year follow-up. Objective:Because the fractional curve (FC) of adult scoliosis can cause radiculopathy, we evaluated patients treated with either circumferential minimally invasive surgery (cMIS) or open surgery. Methods:A multicenter retrospective adult deformity review was performed. Patients included: age >18 years with FC >10°, ≥3 levels of instrumentation, 2-year follow-up, and one of the following: coronal Cobb angle (CCA) > 20°, pelvic incidence and lumbar lordosis (PI-LL) > 10°, pelvic tilt (PT) > 20°, and sagittal vertical axis (SVA) > 5 cm. Results:The FC was treated in 118 patients, 79 open and 39 cMIS. The FCs had similar coronal Cobb angles preoperative (17° cMIS, 19.6° open) and postoperative (7° cMIS, 8.1° open), but open had more levels treated (12.1 vs 5.7). cMIS patients had greater reduction in VAS leg (6.4 to 1.8) than open (4.3 to 2.5). With propensity matching 40 patients for levels treated (cMIS: 6.6 levels, N = 20; open: 7.3 levels, N = 20), both groups had similar FC correction (18° in both preoperative, 6.9° in cMIS and 8.5° postoperative). Open had more posterior decompressions (80% vs 22.2%, P < .001). Both groups had similar preoperative (Visual Analogue Scale [VAS] leg 6.1 cMIS and 5.4 open) and postoperative (VAS leg 1.6 cMIS and 3.1 open) leg pain. All cMIS patients had interbody grafts; 35% of open did. There was no difference in change of primary CCA, PI-LL, LL, Oswestry Disability Index, or VAS Back. Conclusion:Patients' FCs treated with cMIS had comparable reduction of leg pain compared with those treated with open surgery, despite significantly fewer cMIS patients undergoing direct decompression
Concert recording 2019-04-09a
[Track 1]. Fanfare / James Barnes -- [Track 2]. Contrapunctus IX / J.S. Bach ; arranged by Michael Forbes -- [Track 3]. Celestial suite. I. Eclipse ; [Track 4]. II. Canzone lunaire. Pt. 1 ; [Track 5]. Pt. 2 ; [Track 6]. III. Solar plexus / Stephen Bulla -- [Track 7]. Misty Mountain / Howard ; arranged by Cody Hutchison -- [Track 8]. Passage to Bangkok / Rush ; arranged by Cody Hutchison -- [Track 9]. Power ; [Track 10]. Ballade / John Stevens -- [Track 11]. Cherokee / John Schooley -- [Track 12]. Go / Michael Forbes -- [Track 13]. Canzona Bergamasca / Samuel Scheidt ; arranged by Cody Hutchison -- [Track 14]. Shenandoah / traditional ; arranged by Erb. ; translated by Hutchison -- [Track 15]. War Machine / Anthony O\u27Toole
The distance of M33 and the stellar population in its outskirts
We present deep V,I photometry of two $9.4' x 9.4' field in the outer regions
of the M33 galaxy. We obtain a robust detection of the luminosity of the Red
Giant Branch Tip (I{TRGB}=20.72 +- 0.08) from which we derived a new estimate
of the distance modulus of M33, (m-M)_0=24.64 +- 0.15, corresponding to a
distance D=847 +- 60 Kpc. By comparison of the color and magnitude of the
observed Red Giant Branch stars with ridge lines of template globular clusters
we obtained the photometric metallicity distribution of the considered fields
in three different metallicity scales. The derived metallicity distributions
are very similar over a range of distances from the galactic center 10' <= R <=
33', and are characterized by a well defined peak at [M/H] ~ -0.7 ([Fe/H] ~
-1.0, in the Zinn & West scale) and a weak metal-poor tail reaching [M/H] ~
-2.0. Our observations demonstrate that Red Giant Branch and Asymptotic Giant
Branch stars have a radial distribution that is much more extended than the
young MS stars associated with the star-forming disc.Comment: 10 pages,10 figures,accepted for publication in Astronomy &
Astrophysic
Recommended from our members
A missense variant in <i>FTCD</i> is associated with arsenic metabolism and toxicity phenotypes in Bangladesh
Inorganic arsenic (iAs) is a carcinogen, and exposure to iAs via food and water is a global public health problem. iAs-contaminated drinking water alone affects >100 million people worldwide, including ~50 million in Bangladesh. Once absorbed into the blood stream, most iAs is converted to mono-methylated (MMA) and then di-methylated (DMA) forms, facilitating excretion in urine. Arsenic metabolism efficiency varies among individuals, in part due to genetic variation near AS3MT (arsenite methyltransferase; 10q24.32). To identify additional arsenic metabolism loci, we measured protein-coding variants across the human exome for 1,660 Bangladeshi individuals participating in the Health Effects of Arsenic Longitudinal Study (HEALS). Among the 19,992 coding variants analyzed exome-wide, the minor allele (A) of rs61735836 (p.Val101Met) in exon 3 of FTCD (formiminotransferase cyclodeaminase) was associated with increased urinary iAs% (P = 8x10-13), increased MMA% (P = 2x10-16) and decreased DMA% (P = 6x10-23). Among 2,401 individuals with arsenic-induced skin lesions (an indicator of arsenic toxicity and cancer risk) and 2,472 controls, carrying the low-efficiency A allele (frequency = 7%) was associated with increased skin lesion risk (odds ratio = 1.35; P = 1x10-5). rs61735836 is in weak linkage disequilibrium with all nearby variants. The high-efficiency/major allele (G/Valine) is human-specific and eliminates a start codon at the first 5´-proximal Kozak sequence in FTCD, suggesting selection against an alternative translation start site. FTCD is critical for catabolism of histidine, a process that generates one-carbon units that can enter the one-carbon/folate cycle, which provides methyl groups for arsenic metabolism. In our study population, FTCD and AS3MT SNPs together explain ~10% of the variation in DMA% and support a causal effect of arsenic metabolism efficiency on arsenic toxicity (i.e., skin lesions). In summary, this work identifies a coding variant in FTCD associated with arsenic metabolism efficiency, providing new evidence supporting the established link between one-carbon/folate metabolism and arsenic toxicity
Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response
BACKGROUND: The absence of the putative DNA/RNA helicase Schlafen11 (SLFN11) is thought to cause resistance to DNAdamaging agents (DDAs) and PARP inhibitors.
METHODS: We developed and validated a clinically applicable SLFN11 immunohistochemistry assay and retrospectively correlated
SLFN11 tumour levels to patient outcome to the standard of care therapies and olaparib maintenance.
RESULTS: High SLFN11 associated with improved prognosis to the first-line treatment with DDAs platinum-plus-etoposide in SCLC
patients, but was not strongly linked to paclitaxel–platinum response in ovarian cancer patients. Multivariate analysis of patients
with relapsed platinum-sensitive ovarian cancer from the randomised, placebo-controlled Phase II olaparib maintenance
Study19 showed SLFN11 tumour levels associated with sensitivity to olaparib. Study19 patients with high SLFN11 had a lower
progression-free survival (PFS) hazard ratio compared to patients with low SLFN11, although both groups had the benefit of
olaparib over placebo. Whilst caveated by small sample size, this trend was maintained for PFS, but not overall survival, when
adjusting for BRCA status across the olaparib and placebo treatment groups, a key driver of PARP inhibitor sensitivity.
CONCLUSION: We provide clinical evidence supporting the role of SLFN11 as a DDA therapy selection biomarker in SCLC and
highlight the need for further clinical investigation into SLFN11 as a PARP inhibitor predictive biomarker
- …